close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

94.92 +7.14 (+8.14%)
Streaming Delayed Price Updated: 10:00 AM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,684,371
Open 91.02
Bid (Size) 94.80 (1)
Ask (Size) 95.00 (2)
Prev. Close 87.78
Today's Range 90.83 - 96.29
52wk Range 31.36 - 104.32
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AI Stocks Ride a Volatile Wave Amidst Unprecedented Growth and Bubble Fears
October 20, 2025 - The artificial intelligence (AI) sector continues to be a dominant force in the financial markets, driving significant gains and pushing major indices to new highs. Despite a... 
Via MarketMinute
Topics Artificial Intelligence Economy Fraud
Beyond The Numbers: 7 Analysts Discuss Tempus AI Stock
 
Via Benzinga
Topics Artificial Intelligence

Performance

YTD
+177.2%
+177.2%
1 Month
+7.6%
+7.6%
3 Month
+63.6%
+63.6%
6 Month
+131.6%
+131.6%
1 Year
+95.0%
+95.0%

More News

Read More
Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity
From Ambry Genetics
Via Business Wire
Whitehawk Therapeutics Stock Rallies 25% On Tempus AI Collaboration Deal: Retail Hopes For A Rally Toward $5 Mark
Via Stocktwits
Topics Artificial Intelligence
IonQ, Tempus AI And AeroVironment Are Among Top 10 Large Cap Losers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio?
Via Benzinga
Topics Artificial Intelligence
Whitehawk Therapeutics Dips Over 8% In After-Hours Trading Despite New Tempus AI Partnership
Via Benzinga
Topics Artificial Intelligence
Whitehawk Therapeutics Stock Is Trading Higher Thursday: What's Going On?
Via Benzinga
Topics Artificial Intelligence
Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research
From Tempus AI, Inc.
Via Business Wire
Tempus AI Hits $100—Are Shares Due for a Pullback?
Via MarketBeat
Topics Artificial Intelligence Government Initial Public Offering
Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
From Tempus AI, Inc.
Via Business Wire
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns
Via Benzinga
Topics Artificial Intelligence
Nancy Pelosi, Cathie Wood Align On These 4 Stocks – Do You Own Any?
Via Benzinga
Topics Artificial Intelligence
Tempus AI Up Nearly 185% Since Nancy Pelosi's Reported Purchase In January 2025
Via Benzinga
Topics Artificial Intelligence
Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy
From Tempus AI, Inc.
Via Business Wire
Tempus AI's $100 Breakout — Billionaire Cliff Asness Reaps 60% Windfall
Via Benzinga
Topics Artificial Intelligence
Tempus AI Executive Ryan Fukushima Sells $460,000 Worth Of Stock
Via Benzinga
Topics Artificial Intelligence
These 5 Beaten-Down Tech Stocks Could Catch Fire Next
Via MarketBeat
Topics Artificial Intelligence
Nancy Pelosi's Tempus Play Might Be Smartest Trade In Washington — Stock Surges 200%
Via Benzinga
Topics Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Tempus AI Stock Was Motoring Higher This Week
Via The Motley Fool
Topics Artificial Intelligence
AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants
Via MarketMinute
Topics Artificial Intelligence
Tempus AI (TEM) Stock Is Rising Wednesday: What's Going On?
Via Benzinga
Topics Artificial Intelligence
Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
From Ambry Genetics
Via Business Wire

Frequently Asked Questions

Is Tempus AI, Inc. - Class A Common Stock publicly traded?
Yes, Tempus AI, Inc. - Class A Common Stock is publicly traded.
What exchange does Tempus AI, Inc. - Class A Common Stock trade on?
Tempus AI, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tempus AI, Inc. - Class A Common Stock?
The ticker symbol for Tempus AI, Inc. - Class A Common Stock is TEM on the Nasdaq Stock Market
What is the current price of Tempus AI, Inc. - Class A Common Stock?
The current price of Tempus AI, Inc. - Class A Common Stock is 94.92
When was Tempus AI, Inc. - Class A Common Stock last traded?
The last trade of Tempus AI, Inc. - Class A Common Stock was at 10/20/25 10:00 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today